| abstract |
The present invention includes an antibody or antibody fragment that binds to myelin oligodendrocyte glycoprotein (MOG), a hybridoma that produces the antibody or the antibody fragment, and a nucleotide sequence encoding the antibody or the antibody fragment. Nucleic Acid, Transformed Cell Containing Vector Containing the Nucleic Acid, Method for Producing the Antibody or Antibody Fragment, Composition Containing the Antibody or Antibody Fragment, and Antigen Present in the Brain Using the Antibody or Antibody Fragment The present invention relates to a method of detecting or measuring, a method of diagnosing or treating a brain disease, a method of improving brain retention of an antibody, and a method of increasing the amount of antibody in the brain. |